Ann: 2022 Annual Report to shareholders, page-11

I had emailed the company concerning the long amount of time for lab assays and I received an email from the CFO right away..This is his reply:

Thanks for your email and understand your frustration, its shared internally.

To address the slow turn around, we have retendered to the major labs and have identified a more optimal pathway going forward. We have a major drill program beginning in November and as a result of the retendering, expect assay turnaround times to drop by several weeks.

We will also be releasing an update at Moora shortly as well.